Trial Profile
Monitoring The Anticoagulatory Effects of Dabigatran and Rivaroxaban On Plasmatic and Cellular Coagulation by Rotational Thrombelastometry/-Graphy and Multiple Platelet Function Analyzer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Embolism; Stroke
- Focus Pharmacodynamics
- 05 Nov 2012 New trial record